IL205860A - Pharmaceutical compositions containing bradykinin antagonists and hyaluronic acid - Google Patents

Pharmaceutical compositions containing bradykinin antagonists and hyaluronic acid

Info

Publication number
IL205860A
IL205860A IL205860A IL20586010A IL205860A IL 205860 A IL205860 A IL 205860A IL 205860 A IL205860 A IL 205860A IL 20586010 A IL20586010 A IL 20586010A IL 205860 A IL205860 A IL 205860A
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
hyaluronic acid
bradykinin
methyl
osteoarthritis
Prior art date
Application number
IL205860A
Other languages
English (en)
Other versions
IL205860A0 (en
Original Assignee
Luso Farmaco Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Luso Farmaco Inst filed Critical Luso Farmaco Inst
Publication of IL205860A0 publication Critical patent/IL205860A0/en
Publication of IL205860A publication Critical patent/IL205860A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
IL205860A 2007-11-23 2010-05-20 Pharmaceutical compositions containing bradykinin antagonists and hyaluronic acid IL205860A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT002225A ITMI20072225A1 (it) 2007-11-23 2007-11-23 "composizioni farmaceutiche a base di antagonisti della bradichinina ed acido ialuronico e loro uso"
PCT/EP2008/009451 WO2009065507A2 (en) 2007-11-23 2008-11-10 Pharmaceutical compositions containing bradykinin antagonists and hyaluronic acid, and uses thereof

Publications (2)

Publication Number Publication Date
IL205860A0 IL205860A0 (en) 2010-11-30
IL205860A true IL205860A (en) 2013-01-31

Family

ID=40314753

Family Applications (1)

Application Number Title Priority Date Filing Date
IL205860A IL205860A (en) 2007-11-23 2010-05-20 Pharmaceutical compositions containing bradykinin antagonists and hyaluronic acid

Country Status (40)

Country Link
US (1) US9101627B2 (sr)
EP (1) EP2222275B1 (sr)
JP (1) JP5383695B2 (sr)
KR (1) KR101585868B1 (sr)
CN (1) CN101868225B (sr)
AP (1) AP2628A (sr)
AR (1) AR069407A1 (sr)
AT (1) ATE529096T1 (sr)
AU (1) AU2008328311B2 (sr)
BR (1) BRPI0820402A2 (sr)
CA (1) CA2706398C (sr)
CL (1) CL2008003475A1 (sr)
CO (1) CO6270301A2 (sr)
CR (1) CR11457A (sr)
CY (1) CY1112134T1 (sr)
DK (1) DK2222275T3 (sr)
EA (1) EA017626B1 (sr)
EC (1) ECSP10010153A (sr)
ES (1) ES2374861T3 (sr)
GE (1) GEP20125602B (sr)
HN (1) HN2010001037A (sr)
HR (1) HRP20110904T1 (sr)
IL (1) IL205860A (sr)
IT (1) ITMI20072225A1 (sr)
MA (1) MA31913B1 (sr)
MX (1) MX2010005484A (sr)
MY (1) MY148685A (sr)
NI (1) NI201000087A (sr)
NZ (1) NZ585514A (sr)
PA (1) PA8804801A1 (sr)
PE (1) PE20091422A1 (sr)
PL (1) PL2222275T3 (sr)
PT (1) PT2222275E (sr)
RS (1) RS52045B (sr)
SI (1) SI2222275T1 (sr)
TN (1) TN2010000215A1 (sr)
TW (1) TWI448292B (sr)
UA (1) UA97867C2 (sr)
WO (1) WO2009065507A2 (sr)
ZA (1) ZA201003586B (sr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2016148820A (ru) * 2014-05-30 2018-07-04 Наталия Мыколаивна Деркач Стабилизированный раствор на основе активных веществ, способ получения стабилизированного раствора активных веществ, фармацевтическая композиция на основе стабилизированного раствора активных веществ (варианты)
CA2972212C (en) 2014-12-26 2024-10-29 Seikagaku Corporation AGENT AND IMPROVEMENT OF SUBJECTIVE OCULAR SYMPTOMS AND ASSOCIATED METHOD
EP3636752A4 (en) 2018-07-25 2021-04-28 Alteogen, Inc. NEW HYALURONIC ACID HYDROLYZING ENZYMUTANTS AND THE PHARMACEUTICAL COMPOSITION CONTAINING THIS
MY204342A (en) 2019-03-25 2024-08-24 Alteogen Inc Pharmaceutical composition, comprising human hyaluronidase ph20 variant and drug, for subcutaneous injection
US11401303B2 (en) * 2020-06-15 2022-08-02 Taian City Qihang Biotechnology Co. Synthetic peptide BRAP and application in preparation of anti-inflammatory drug for COVID-19 thereof
JP7622088B2 (ja) 2020-08-07 2025-01-27 アルテオジェン・インコーポレイテッド 組換えヒアルロニダーゼの生産方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7635489B2 (en) * 2001-05-18 2009-12-22 Leneau Holdings, Llc Ingestion of hyaluronic acid for improved joint health
ITMI20021247A1 (it) * 2002-06-07 2003-12-09 Menarini Ricerche Spa Antagonisti basici non peptidici della bradichinina e loro impiego informulazioni farmaceutiche
ITMI20041963A1 (it) * 2004-10-15 2005-01-15 Luso Farmaco Inst "antagonisti non-peptidici della bradichinina e loro composizioni farmaceutiche"

Also Published As

Publication number Publication date
MX2010005484A (es) 2010-06-07
GEP20125602B (en) 2012-08-10
ES2374861T3 (es) 2012-02-22
HRP20110904T1 (hr) 2011-12-31
EP2222275A2 (en) 2010-09-01
AU2008328311B2 (en) 2013-02-28
NZ585514A (en) 2012-01-12
TWI448292B (zh) 2014-08-11
CA2706398C (en) 2016-07-05
US20100292156A1 (en) 2010-11-18
PL2222275T3 (pl) 2012-03-30
JP5383695B2 (ja) 2014-01-08
BRPI0820402A2 (pt) 2015-05-19
PT2222275E (pt) 2012-01-16
HK1149714A1 (en) 2011-10-14
EA201000678A1 (ru) 2010-12-30
PA8804801A1 (es) 2009-06-23
CL2008003475A1 (es) 2009-03-27
JP2011504473A (ja) 2011-02-10
KR20100096106A (ko) 2010-09-01
AU2008328311A1 (en) 2009-05-28
HN2010001037A (es) 2012-12-10
TN2010000215A1 (en) 2011-11-11
AP2010005265A0 (en) 2010-06-30
CN101868225A (zh) 2010-10-20
CN101868225B (zh) 2013-06-12
RS52045B (sr) 2012-04-30
TW200927151A (en) 2009-07-01
SI2222275T1 (sl) 2012-01-31
ITMI20072225A1 (it) 2009-05-24
IL205860A0 (en) 2010-11-30
WO2009065507A2 (en) 2009-05-28
CY1112134T1 (el) 2015-11-04
CR11457A (es) 2010-11-05
EP2222275B1 (en) 2011-10-19
US9101627B2 (en) 2015-08-11
PE20091422A1 (es) 2009-10-17
CA2706398A1 (en) 2009-05-28
EA017626B1 (ru) 2013-01-30
WO2009065507A3 (en) 2009-09-03
ZA201003586B (en) 2011-08-31
KR101585868B1 (ko) 2016-01-22
UA97867C2 (ru) 2012-03-26
CO6270301A2 (es) 2011-04-20
ECSP10010153A (es) 2010-06-29
NI201000087A (es) 2011-07-18
MA31913B1 (fr) 2010-12-01
AP2628A (en) 2013-03-26
MY148685A (en) 2013-05-31
ATE529096T1 (de) 2011-11-15
DK2222275T3 (da) 2012-01-02
AR069407A1 (es) 2010-01-20

Similar Documents

Publication Publication Date Title
KR101669682B1 (ko) 골관절 질환의 치료 및/또는 예방에 사용하기 위한 약학 조성물
US9101627B2 (en) Pharmaceutical compositions containing bradykinin antagonists and hyaluronic acid, and uses thereof
JP2012528132A (ja) 注射による皮膚反応を減少させるための、アドレナリン受容体アゴニストと充填剤との注射可能な組合せ
JP2019535647A (ja) 徐放ｃｎｐ作動薬を用いた併用療法
EP2090307A1 (en) Pharmaceutical composition for the treatment or prevention of osteoarticular diseases
US12084471B2 (en) Amino acid derivative of glucosamine stimulating extracellular matrix synthesis and pharmaceutical composition comprising the same
KR102285724B1 (ko) Dna 단편 혼합물 및 히알루론산을 포함하는 연골 재생용 조성물
TW201726146A (zh) 用於預防及治療眼疼痛之氨基膦衍生物
KR20220152904A (ko) Dna 분획물 및 콘드로이틴 설페이트를 포함하는 관절염 예방 또는 치료용 조성물
EP2090308A1 (en) Pharmaceutical composition for the treatment or prevention of osteoarticular diseases
CN118001373B (zh) 一种治疗骨关节炎的药物
HK1149714B (en) Pharmaceutical compositions containing bradykinin antagonists and hyaluronic acid, and uses thereof
US12594297B2 (en) Composition comprising hyaluronic acid and pluronic for preventing or treating articular and cartilage injury
RU2827073C1 (ru) Средство для лечения артрологических заболеваний в лиофилизированной форме для инъекций
HK40073499A (en) Composition comprising hyaluronic acid and pluronic for preventing or treating articular and cartilage injury
HK1149717B (en) Pharmaceutical composition for use in the treatment and/or the prevention of osteoarticular diseases

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees